166 related articles for article (PubMed ID: 21972953)
1. Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Matsushita S; Yonekura K; Mera K; Kawai K; Kanekura T
J Dermatol; 2011 Oct; 38(10):996-8. PubMed ID: 21972953
[No Abstract] [Full Text] [Related]
2. S-1 in combination with docetaxel as salvage therapy for patients with metastatic extramammary Paget's disease.
Fukuda K; Hirai I; Nakamura Y; Fusumae T; Tanese K; Yaguchi T; Kawakami Y; Funakoshi T
Eur J Dermatol; 2020 Jun; 30(3):301-302. PubMed ID: 32540820
[No Abstract] [Full Text] [Related]
3. Case of metastatic extramammary Paget's disease treated with trastuzumab-biosimilar monotherapy after S-1 and docetaxel combination chemotherapy.
Kimura T; Akamatsu Y; Kajihara I; Fukushima S; Ihn H
J Dermatol; 2020 Jan; 47(1):e1-e2. PubMed ID: 31571250
[No Abstract] [Full Text] [Related]
4. Achieved good response of S-1 and docetaxel combination chemotherapy in two patients with metastatic extramammary Paget's disease.
Egashira S; Kajihara I; Kanemaru H; Uemura-Kiyohara M; Yamada-Kanazawa S; Nakahara S; Nagamoto E; Fukushima S; Jinnin M; Inoue Y; Ihn H
J Dermatol; 2017 May; 44(5):e103-e104. PubMed ID: 27882581
[No Abstract] [Full Text] [Related]
5. Successful treatment of bilateral multiple lymph node metastases in extramammary Paget's disease with surgery and sequential chemotherapy of S-1 and docetaxel.
Ogata D; Hokama Y; Tsuchida T
J Dermatol; 2015 Dec; 42(12):1193-4. PubMed ID: 26331378
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy with S-1 and docetaxel for cutaneous angiosarcoma resistant to paclitaxel.
Kajihara I; Kanemaru H; Miyake T; Aoi J; Masuguchi S; Fukushima S; Jinnin M; Ihn H
Drug Discov Ther; 2015 Feb; 9(1):75-7. PubMed ID: 25788055
[TBL] [Abstract][Full Text] [Related]
7. Metastatic extramammary Paget's disease successfully controlled with tumour dormancy therapy using docetaxel.
Fujisawa Y; Umebayashi Y; Otsuka F
Br J Dermatol; 2006 Feb; 154(2):375-6. PubMed ID: 16433815
[No Abstract] [Full Text] [Related]
8. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
Hirai I; Funakoshi T
J Dermatol; 2017 Oct; 44(10):1148-1151. PubMed ID: 28406527
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Kawakita R; Fusumae T; Oda S; Takeuchi A; Takasugi A; Yoshida T
J Dermatol; 2018 Sep; 45(9):e252-e253. PubMed ID: 29572930
[No Abstract] [Full Text] [Related]
10. S-1 induced a durable response in metastatic extramammary Paget's disease.
Mikoshiba Y; Uhara H; Kubo H; Okuyama R
J Dermatol; 2013 Aug; 40(8):664-5. PubMed ID: 23682853
[No Abstract] [Full Text] [Related]
11. Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.
Oguchi S; Kaneko M; Uhara H; Saida T
J Dermatol; 2002 Jan; 29(1):33-7. PubMed ID: 11837572
[TBL] [Abstract][Full Text] [Related]
12. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.
Yamazaki N; Yamamoto A; Wada T; Ishikawa M; Moriya Y; Nakanishi Y
J Dermatol; 1999 May; 26(5):311-6. PubMed ID: 10380432
[TBL] [Abstract][Full Text] [Related]
13. Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases.
Kato J; Hida T; Yamashita T; Kamiya S; Horimoto K; Sato S; Takahashi H; Sawada M; Yamada M; Uhara H
J Dermatol; 2018 Jan; 45(1):80-82. PubMed ID: 28891079
[TBL] [Abstract][Full Text] [Related]
14. Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.
Kojima Y; Yamada Y; Kamisawa H; Sasaki S; Hayashi Y; Kohri K
Int J Urol; 2006 Aug; 13(8):1123-5. PubMed ID: 16903943
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
[TBL] [Abstract][Full Text] [Related]
16. Metastatic extramammary Paget's disease: dramatic response to combined modality treatment.
Balducci L; Athar M; Smith GF; Khansur T; McKenzie D; Crawford ED
J Surg Oncol; 1988 May; 38(1):38-44. PubMed ID: 2836660
[TBL] [Abstract][Full Text] [Related]
17. Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy.
Takahagi S; Noda H; Kamegashira A; Madokoro N; Hori I; Shindo H; Mihara S; Hide M
J Dermatol; 2009 Aug; 36(8):457-61. PubMed ID: 19691751
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Hironaka S; Yamazaki K; Taku K; Yokota T; Shitara K; Kojima T; Ueda S; Machida N; Muro K; Boku N
Jpn J Clin Oncol; 2010 Nov; 40(11):1014-20. PubMed ID: 20603245
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
[TBL] [Abstract][Full Text] [Related]
20. Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.
Koizumi S; Doi R; Aitake U; Lei X; Izumi T; Mori T; Shojiguchi N; Kawasaki T; Inozume T; Kishi A
J Dermatol; 2024 Jun; 51(6):e203-e204. PubMed ID: 38216840
[No Abstract] [Full Text] [Related]
[Next] [New Search]